Systems Oncology Approach to Optimize Ovarian Cancer Treatment

The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.

NCT Number	NCT06117384
Lead Sponsor	University of Helsinki Collaborators: Helsinki University Central Hospital
Conditions	Ovarian Cancer
Enrollment	500 participants
Start Date	2022-01-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2023-11-07